During menopause, these changes in ERβ expression are correlated with menopausal metabolic disorders and osteoporosis; therefore, regulating ERβ can be a strategy for attenuating menopausal symptoms [6, 23, 33]. This evidence concerns the gene ESR2 and osteoporosis.